Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Birth Defects Res A Clin Mol Teratol. Author manuscript; available in PMC 2010 October 1.
Published in final edited form as:
PMCID: PMC2760641




Untreated, more than 95% of female SWR × NZB: F1 (SNF1) mice spontaneously develop a fatal lupus-like glomerulonephritis by 8 months-of-age, while disease onset in males is much slower.


Timed-pregnant SNF1 mice (10/treatment) were exposed to TCDD on gestational day (GD) 12 by oral maternal gavage with 0, 40 or 80 μg/kg TCDD.


Offspring of the TCDD-exposed dams showed numerous alterations in T lineage cells at 24 weeks-of-age. Females but not males showed decreased CD4+8+ and increased CD48 thymocytes. Females also showed increased autoreactive CD4+Vβ17a+ axillary and inguinal lymph node T cells. Con-A stimulated splenocytes from prenatal TCDD-treated mice produced decreased IL-17 in the females while males showed increased IL-2 and IFN-γ, and diminished IL-4. Mitogen-stimulated pan-lymphoproliferative responses were significantly increased across sex by TCDD. Anti-IgG and anti-C3 immune complex deposition in kidneys was present in the males after TCDD, and visibly worsened in females.


Developmental TCDD exposure can permanently alter T lymphopoiesis in autoimmune-prone SNF1 mice. The alteration profile is beyond the classic immune suppression response, to also include exacerbation and induction of a lupus-like autoimmune disease.

Keywords: TCDD, prenatal exposure, T cells, autoimmunity, SNF1 mouse


Exposure of rodents to different immunotoxic agents during the perinatal establishment of the immune system causes persistent immune function deficits in the offspring (Dietert and Piepenbrink, 2006; Holladay and Smialowicz, 2000). For instance, pregnant rodent exposure to low levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) impaired cytotoxic T lymphocyte activity of offspring until 10 weeks of age (Holladay and others, 1991) and permanently depressed delayed-type hypersensitivity responses (Gehrs and Smialowicz, 1999). These effects of TCDD on the immune system are primarily mediated through the aromatic hydrocarbon receptor (AhR) (Hogaboam and others, 2008; Hundeiker and others, 1999) and are greatly influenced by the affinity of the AhR (high vs low) relative to the dose of TCDD encountered. For example, SNF1 mice express a low affinity AhR and require an approximately 8-fold increase in TCDD dose to equal the high-affinity C57BL/6 response (Mustafa and others, 2008).

Besides causing immune suppression, several reports suggest TCDD may increase the risk of autoimmunity. Mice treated in vivo with monoclonal antibodies to MHC class I and class II molecules displayed inhibited thymocyte differentiation, similar to that occurring spontaneously in murine models of autoimmune disease (Kakkanaiah and others, 1990; Kruisbeek and others, 1985) or after TCDD (Blaylock and others, 1992). These thymic MHC class I and class II antigens are required for normal thymocyte differentiation as well as for deletion of autoreactive cells (Blaylock and others, 1992). DeWaal et al. (1992) observed reduced thymic epithelial MHC class II antigen expression in TCDD-treated mice, while Dong et al. (1997) found that TCDD down-regulated an MHC class I gene (Q1b) in a mouse hepatoma cell line. The MHC Q1b cDNA encodes for the α3 domain and transmembrane domain of the Q1b class I protein, implying that the MHC gene product could interact with β2-microglobulin, and as such function in antigen presentation. In another study, TCDD was shown to increase the expression of MHC class II molecules on splenic Dendritic cells (DC) in the absence of antigen suggesting that TCDD modulates the processing and presentation of antigen in thymic DC, thus altering the CD4 thymocyte selection process (Vorderstrasse and others, 2003). These effects on MHC class I and II molecules by TCDD raised questions regarding the ability of TCDD to impair autoreactive thymocyte deletion (Holladay, 1999). In support of the possibility TCDD may impair T cell selection, Silverstone et al. (1994) observed T cells expressing elevated levels of CD4+ Vβ17a and Vβ 3+ TCR in the livers of TCDD-treated mice. Such TCR variable β (Vβ) chains are usually deleted in the thymus by reaction with self-MHC and minor lymphocyte stimulatory antigens (Hanawa and others, 1993; Okuyama and others, 1992) and have been associated with autoimmunity in experimental mouse models (Rocha and others, 1992).

The incidence of nephritis is low in autoimmune NZB mice, but when this strain is crossed with normal SWR mice, almost 100% of the female SNF1 hybrids develop a fatal glomerulonephritis. The progression of autoimmune disease in these lupus-like SNF1 mice, as in the human version of the disease, is critically dependent on accelerated antibody production subsequent to inappropriate activity of CD4+ T helper cells. This autoimmune nephritis is thus characterized by IgG deposition in kidney glomeruli (Mohan and others, 1993).

Silverstone et al. (1998) exposed SNF1 mice to TCDD during mid-gestation, and reported an early onset of glomerulonephritis not normally observed in the males at 24 weeks-of-age. Mechanisms underlying this early induction of autoimmunity in the male SNF1 mice by TCDD are not known, and are important for understanding environmental influences on disease initiation and expression. In the current study, we hypothesized that prenatal exposure to TCDD in SNF1 mice may produce permanent defects in T cell development, maturation and function that will correspond to acceleration or exacerbation of autoimmune lupus. Detecting such changes is necessary to guide later studies aimed at determining how TCDD may act as potential risk factor in the development of autoimmune diseases.

Methods and Materials

Mice and TCDD exposure

SWR × NZB (SNF1) mice were obtained by breeding male NZB mice with female SWR/J mice, both from Jackson Laboratories (Bar Harbor, ME). Mice (4–5 weeks-of-age) were acclimated to the animal care facility for at least 2 weeks prior to breeding. Briefly, 60 SWR females were bred to 30 NZB males overnight in cages containing one NZB male per two SWR females. Plug positive mice, evaluated the next morning, were designated gestation day (GD) 0. Pregnant SWR mice were orally gavaged on GD 12 with 0, 40 or 80 μg/kg TCDD dissolved in corn oil (N= 10 pregnant mice/treatment). The SNF1 offspring were weaned at 20–21days and separated by treatment, allowed to mature to 24 weeks-of-age, and evaluated for changes in immune status. All animals were fed a commercial pelleted diet, provided water ad libitum, and housed under controlled conditions of temperature (22 °C), humidity (40–60%), and lighting (12:12 light:dark cycle). Animal maintenance, care and use were approved prior to initiation of experiments and at all times were in accordance with Institutional Animal Care and Use Committee (IACUC) guidelines at Virginia Tech.

Body weights and tissue collection

Mice at 24 weeks-of-age were euthanized by cervical dislocation and weighed. Left untreated, females are in early stages of lupus nephritis and males are free of clinical signs (Eastcott and others, 1983). The thymus, spleen, and axillary and inguinal lymph nodes were immediately collected post-euthanasia under aseptic conditions, using dissection scissors and curved forceps. The spleen and thymus were weighed and then all tissues were placed individually into pre-labeled sterile Petri dishes (Corning, Corning, NY), containing 8 mL of RPMI-1640 culture medium (Mediatech, Herndon,VA). Dishes were placed on ice until tissue dissociation.

Cell dissociation and enrichment

Each organ was gently dissociated over a stainless steel sieve screen (Sigma, St. Louis, MO) using curved forceps. Cells were then pipetted through the sieve screen following dissociation to remove debris. Cells were washed in incomplete RPMI-1640 for 10 min, 240 × g, and 23 °C. The supernatant was discarded and, with the exception of spleen, the cell pellet was resuspended in 8 mL of RPMI-1640. Spleen cells were resuspended in 1 mL incomplete RPMI-1640. To each tube, 2 mL of 0.83% ammonium chloride lysis buffer (ACK, pH 7.29) were added, to lyse red blood cells, and tubes were incubated for 5 min at 23 °C. After lysis incubation, the cells were resuspended in 5 mL of incomplete RPMI-1640 and washed twice (7 min, 290 × g and 7 °C). The splenic leukocyte-rich cells were then resuspended in 5 mL complete RPMI-1640 media containing 10% heat-inactivated FBS (Atlanta Biologicals, Atlanta, GA), 2 mM L-glutamine (ICN, Costa Mesa, CA), 50 IU/mL penicillin (ICN), and 50 mg/mL of streptomycin (ICN), and maintained at 7–10 °C.

Cell enumeration

Cells were enumerated and size-analyzed using a Beckman Multisizer 3® Cell Coulter (Beckman Coulter, Fullerton, CA) according to the manufacturer's protocol. Briefly, a 10 μL aliquot of enriched cell suspension was transferred to a plastic counting-chamber containing 10 mL of PBS (Mediatech). The plastic chamber was capped, mixed by repeated gentle inversion, and counted. The cells were enumerated and adjusted to 5.0 × 106 cells/mL in complete RPMI-1640 media.

Flow cytometric evaluation of cell-surface markers

Cell suspensions (5 × 105/100 μL) from the thymus, spleen, and lymph nodes were dispensed into individual wells of a 96-well round-bottom tissue culture plate (Corning). Monoclonal antibodies (mAbs) with phycoerythrin (PE) fluorescent labels were used according to manufacturer's (BD Pharmingen; San Diego, CA) recommendation at a concentration of 0.2 μg/μL; mAbs with fluorescein isothiocyanate (FITC) fluorescent labels were similarly used at the recommended concentration of 0.5 μg/μL. Cells were stained as previously described (Mustafa et al., 2008). Briefly, lymphocyte aliquots (5 × 105 cells/ 100 μL) from thymus, spleen, and lymph nodes were incubated with the following primary mAbs: PE-anti CD4, FITC-anti CD8, FITC-anti CD25, FITC-anti Vβ3 TCR (KJ25), or FITC-anti Vβ17a TCR (KJ23) (BD Pharmingen). For double staining protocols, mAbs with different fluorescent labels were simultaneously added to the sample. Following staining, cells were washed and evaluated on a Coulter Epics XL flow cytometer (Beckman Coulter). From each sample, 10000 events were collected and analyzed using the FlowJo software (Tree Star, San Carlos, CA). Dead cells, clumps, and debris were excluded electronically by gating on forward scatter (FSC) versus side scatter (SSC).

Immunohistochemistry of the kidneys: C3 and IgG deposition

Kidneys were collected at the time of euthanasia and sectioned for immunohistochemistry. The immunohistochemistry section was embedded in OCT media (Miles, Elkhart, IN) and frozen at −80 °C for cryosections. Frozen kidneys were cut into 5 μm sections and stained with FITC conjugated antibodies. Briefly, tissue sections were thawed at room temperature and dried for 30 min. Slides were fixed in acetone for 10 min and then washed with PBS thrice for 3 min/wash. Goat anti-mouse IgG diluted 1:100 (MP Biomedicals, Santa Ana, CA) or goat anti-mouse C3 diluted 1:100 (MP Biomedicals) were incubated with tissues sections in a humid chamber for 60 min at 23°C. The sections were then rinsed thrice for 5 min/wash with PBS. The slides were mounted using Vectashield™ mounting media (Vector Labs, Burlingame, CA) and then examined using an Olympus BX-60 fluorescence microscope (Center Valley, PA). The severity of glomerulonephritis and immune complex deposition was scored using a range from 0 to 3+, where 0 corresponded to a non-autoimmune healthy mouse and 3+ to the maximal alteration observed in the study. All slides were scored in a blinded manner independently by an experienced investigator (co-author RG). Scores were averaged for the final tissue score.

Lymphocyte proliferation assay

Splenocytes were plated into each well (5 × 105 cells/ 100 μL per well) of a 96-well round-bottom tissue-culture plate (Corning Cell Wells™, Corning). Cells were exposed to mitogens as follows: 100 μL of: Concanavalin A (Con A, 10 μg/mL, Sigma); or phorbol myristate acetate (PMA, 10 ng/mL, Sigma) plus ionomycin (0.5 μg/ml, Sigma) in complete media. Non-stimulated control cultures contained 100 μL of complete media alone. Triplicate wells were used for each stimulant. Following 48 h incubation, 20 μL of alamarBlue™ dye (Serotec, Raleigh, NC) (10% of incubation volume) were added to each well of the culture plates. At 24 and 48 h post addition, degree of absorbance was determined under dual wavelength (570 and 600 nm) using a Molecular Devices plate reader (Menlo Park, CA).

Cytokine ELISA Assays

Splenocytes were plated into each well (1 mL in complete media; 5 × 106 cells per well) of a 24-well tissue-culture plate (Corning). Cells were co-cultured with 1 mL Con A (10 μg/mL) and incubated at 37 °C, 5% CO2 for 48 h. The plates were centrifuged (7 °C, 250 × g, 7 min), and the supernatants were transferred to sterile 12 × 75 mm cultured tubes (Fisher). Supernatants were stored at − 80 °C until use. The levels of interleukin 2 (IL-2), IL-4, IL-10, IL-12, and interferon-gamma (INF-γ) were determined using ELISA kits (Ready-to-use; ebioscience, San Diego, CA) according to the manufacturer's instructions. IL-17 levels were measured using the Searchlight Mouse Cytokine Array (Pierce Biotechnology Inc. Rockford IL) according to the manufacturer's instructions and imaged using a cooled CCD camera and analyzed using the Arrayvision 8.0 software.

Statistical analysis

Data were expressed as arithmetical mean ± SEM. Analysis of variance (ANOVA) was used with Dunnett's test to establish significant differences in the same sex groups between treatment groups and control. The pregnant dam was maintained as the statistical unit in all cases such that each offspring analyzed represented a separate dam (one pup/sex/treatment). Group size was six SNF1 offspring per sex for all experiments (N=6). Results described as different in this report indicate significantly different at p ≤0.05.


Body and organ weights, and organ cellularity

Body weight of the 24-week-old adult SNF1 offspring was decreased in the males by prenatal exposure to 40 and 80 μg/kg TCDD and 80 μg/kg TCDD in the females. Thymic weight was decreased by 80 μg/kg TCDD in the male offspring only, while thymic cellularity was decreased in both sexes by 80 μg/kg prenatal TCDD. There were no significant differences in splenic weight or the spleen/body weight ratio across treatment groups. In contrast, splenic cellularity was increased, in males but not females, by 80 μg/kg TCDD (Table 1).

Table 1
Body Weight, Organ Weight & Cellularity

Thymic T cell differentiation

Female, but not male, offspring of dams dosed with TCDD exhibited significant thymic phenotypic changes at 24 weeks-of-age. The relative expression of thymic CD4+CD8+ cells was decreased in females by the 80 μg/kg prenatal TCDD dose. In addition, CD4CD8 thymocytes were significantly increased in females at this same TCDD exposure level (Table 2).

Table 2
T cell differentiation Analysis

Spleen T cells

The relative percentage of spleen T cells expressing CD4/CD8 markers did not change in any treatment group, in either sex. However, the absolute number of T cells expressing CD4 was significantly increased in the 40 μg/kg TCDD females and 80 μg/kg TCDD males when compared to corresponding controls (Table 3).

Table 3
Splenic T cell Subset Analysis

T cell subset expression in lymph nodes

The combined axillary and inguinal lymph node CD4/CD8 T cell phenotypes were not different across treatment group or sex compared to controls. However, the 80 μg/kg TCDD females showed significantly increased percentages of CD4+Vβ17a+ TcR T cells. The T cells expressing CD4+CD25+, which include T regulatory and activated T cells, were increased in the 80 μg/kg female and male treatment groups (Table 4).

Table 4
Lymph Node T cell Subset Analysis

Deposition of anti-IgG and anti-C3 immune complexes in the kidney

Since immune complex deposition in the kidney is a common signalment in lupus patients, we employed immunofluorescent staining with antibodies to IgG and C3. Sectioned kidneys from 24-week-old SNF1 offspring stained with anti-IgG and anti-C3 antibodies showed an increasing TCDD dose dependent trend in deposition of immune complexes, which was significant in the males (Figure 1). Anti-C3 staining produced images that very similar to IgG (data not shown).

Figure 1
The kidneys from 24-week-old SNF1 mice that were prenatally exposed to 0, 40 or 80 μg/kg TCDD were collected, fixed, sectioned and stained with FITC-labeled anti-IgG and anti-C3. The above are representative images of kidneys stained with FITC-anti-IgG ...

Mitogen-stimulated splenic lymphocyte proliferation

Mitogen stimulation of enriched, cultured splenic lymphocytes was employed to assess the influence of prenatal TCDD on lymphocyte functionality in the adult mouse. Prenatal TCDD had a selective effect on splenic lymphoproliferative responses of 24 week-old SNF1 offspring. No significant effects on stimulation responses were seen using ConA in splenocytes, at 48 or 72 h. However, the mitogenic response to PMA/Ionomycin (P/I) was significantly enhanced in females at both TCDD exposures, at 48 and 72 h. Enhanced proliferation was also seen in 80 μg/kg TCDD P/I males, at 48 h (Figure 2).

Figure 2
The lymphoproliferative responses of cultured splenocytes in 24-week-old SNF1 mice exposed prenatally to 0, 40 or 80 μg/kg TCDD. Splenocytes were exposed to Con A or P/I for 48 h or 72 h. Values are reported as mean Δ specific absorbance ...

Th1/Th2 cytokine balance

In males, prenatal exposure to TCDD caused a shift toward a Th1 cytokine profile in Con-A-stimulation splenic lymphocytes collected from 24-week-old mice. The 80 μg/kg TCDD males showed enhanced IL-2 and IFN-γ production, and diminished IL-4 production relative to controls. In the female mice, IL-17 production followed a decreasing trend reaching significance at 80 μg/kg TCDD (Figure 3).

Figure 3
Supernatants were collected from splenocytes, of 24-week-old mice that were prenatally exposed to 0, 40 or 80 μg/kg TCDD, and cultured for 48 h with Con A (10 μg/mL). The levels of IL-2, IL-4, IL-10, IL-12, IL-17 and INF-γ were ...


T cells were initially proposed to not play a direct role in tissue damage in SNF1 lupus-like nephritis. However, the proliferation of glomerulus-specific autoantibodies may require interaction between autoreactive T-helper (Th) cells and autoreactive B cells (Mohan and others, 1993). An increase in the CD4 to CD8 ratio of IdLNF1-reactive T cells, suggestive of increased Th cells, was also detected at 22–24 weeks of age in sera of SNF1 mice and coincided with increased IdLNF1 Ig (IgG + IgM) deposition in the kidneys (O'Garra and others, 1992). Further, the presence of pathogenic autoantibody-inducing Th cells specific for chromatin subparticles or histones has been noted in human patients with systemic lupus erythematosus as well as in SNF1 mice (Fournel and others, 2003). Thus, available data suggest that autoimmune nephritis in SNF1 mice might be influenced by a T cell lesion. This is supported by a study showing that postnatal day 3 thymectomy protects SNF1 mice from glomerulonephritis (Bagavant and others, 2002).

In the present study, SNF1 mice exposed developmentally to TCDD varied considerably, by sex and compartment, in both type and severity of immune lesions. Thymic cellularity was approximately equally diminished in the male and female offspring. Mechanisms underlying this effect are not known, but may include bone marrow progenitor T cell damage by TCDD (Fine and others, 1989) or enhancement of precursor T cell death at the thymic level (Rajagopalan and others, 1990; Shivakumar and others, 1989). Female offspring, but not males, showed a dramatic decrease in CD4+8+ cells and increase in CD48 cells. These data suggest prenatal TCDD caused permanent postnatal alterations in thymic T cell maturation in female offspring, in addition to thymocyte hypocellularity.

T cell parameters in the secondary lymphoid organs were not changed by TCDD, with two exceptions. Total spleen CD4+ Th cells tended toward increased numbers in 80 γg/kg TCDD females and were significantly increased, by 79%, in males at the same dose level. Lymph node Vβ TCR expression (autoreactive phenotypes) was unchanged in males, however in females CD3+Vβ3+ TCR expression tended toward increase while CD4+Vβ17a+ TCR expression increased significantly, by 115%. Thymic dendritic cells of SNF1 mice tend to have a lower expression of MHC class II and costimulatory molecules (Michaels and others, 2005). The increase in peripheral Vβ+ Th cells concentrations, above controls, may indicate that TCDD further compromised thymic deletion of autoreactive TCR (negative selection), a possibility previously suggested based on diminished thymic MHC class II antigen expression by TCDD (Holladay, 1999). It is also possible that TCDD may alter the presentation of nucleosomal autoepitopes by the thymic DC in these mice to exacerbate the disease (Michaels and others, 2005). Further, TCDD exposure increased the thymic CD4-CD8 (DN) population. In SNF1 mice, DN Th cells are known inducers of the pathogenic IgG anti-DNA antibodies (Adams and others, 1990).

Altered T cell maturation and Vβ+ Th phenotypes in SNF1 mice, suggest that prenatal TCDD might cause inappropriate T cell function. We therefore surveyed six principle cytokines mitogen-stimulated T cells of the spleen. We observed that cytokine production was permanently changed by prenatal TCDD, in a manner different based on sex. These variations in cytokine levels between the two sexes would appear to correspond to normal sex-based differences in the disease progression at 24 weeks in this murine strain. For example, IL-10 levels were significantly increased in the females compared to the males across all treatments. Currently, it is believed that elevated levels of IL-10 reflect disease activity once lupus inflammation has been initiated. At 24 weeks, SNF1 females are already in the active stage of the disease, which is supported by the elevated levels of IL-10.

IL-10 mitigates the pro-inflammatory function of Th17 and Th1 thus may explain, in part, the lower levels of IL-17 and INFγ observed in the females of this strain at 24 weeks (McGeachy and others, 2007; Yin and others, 2002). Also, INFγ is not believed to be required for later stages of disease which would appear to correlate with the disease progression of these female mice (Nicoletti and others, 1992). Interestingly in this study, prenatal TCDD exposure further suppressed the Th17 and Th1 cytokine profile as indicated by the decreased levels of IL-17 and INFγ in these females compared to controls. One possibility for the decreased IL-17 levels may be the stage of disease progression, in that the IL-17-producing T cells may have already localized within the sites of inflammation, for instance the kidney (Kang and others, 2007). Another possibility is that TCDD modulated the IL-17-producing T cells through the AhR in a ligand-specific manner (Quintana and others, 2008). Further, since the percentage of CD4+CD25+ T cells was increased in the TCDD mice, it is possible that this reflects an expansion of an induced T-reg population (Marshall and others, 2008). It is also likely that a different set of cytokines might contribute to or even orchestrate the florid immune response at advanced stages of SLE. Recent studies have focused on type I IFNs (IFN-α and IFN-β) as there is growing evidence to suggest these IFNs may play a critical role in the pathogenesis of lupus (Banchereau and Pascual, 2006).

In the males, however, prenatal TCDD exposure increased the level of IFNγ and IL-2, and decreased IL-4 suggesting a skewing towards Th1 activity. At 24 weeks, SNF1 males usually do not manifest SLE-like symptoms, however, higher levels of INFγ would appear to correlate with the early onset of the autoimmune disease (Karpuzoglu-Sahin and others, 2001a; Karpuzoglu-Sahin and others, 2001b). For example, increased IFNγ has been associated with development of autoimmune insulitis (Campbell and others, 1991), lupus nephritis (Haas and others, 1997), Sjogren's syndrome (Hayashi and others, 1996) and autoimmune arthritis (Billiau, 1996).

In this study, Con A stimulation was employed to specifically evaluate the function of T cells, in particular the Th cells. Thus, the observed cytokine profile is reflective of T cell signaling. It should be noted that this cytokine profile might shift significantly if the splenocytes had been cultured with other mitogens, for instance the B cell mitogen lipopolysacharide (LPS) or pan-lymphocyte mitogen PMA/ionomycin. Further studies are planned to evaluate in more detail the cytokine signaling under time kinetics using additional mitogens targeting the other immune cells. Beyond altered cytokine production, splenocytes from both sexes of the prenatal TCDD-exposed SNF1 mice displayed enhanced lymphoproliferative responses to a pan-lymphocyte mitogen stimulation at 24 weeks-of-age, supporting a hyperactivity of these cells.

Immunofluorescent staining of the kidney was employed to track lupus-nephritis and to determine if developmental TCDD enhanced autoimmune disease in the present SNF1 mice. Immune complex IgG and C3 deposition was significantly increased in the TCDD-exposed males and displayed a dose-dependent numeric increase in females. Females and males both also showed dose-related trends toward increases in autoimmune-related kidney pathology, in the form of fibrinoid necrosis, crescents and inflammatory cells (data not shown).

In summary, male and female SNF1 mice showed persistent changes in T cells as a consequence of GD 12 exposure to TCDD. Among these were numerous sex-specific effects, suggesting possible interactions with endogenous hormones. The TCDD-exposed mice displayed a clear enhanced autoimmune profile, including increased Vβ+ Th cells, increased T cell proliferative capacity, dysregulated cytokine production toward Th1, and increased autoimmune kidney lesions. Further, it should be noted that these changes were reflective of the disease progression at 24 weeks and may change differently across sex as these animals age. Thus, these collective data show that developmental TCDD permanently alters the postnatal immune system, in a manner beyond the well-established profile of immune suppression, and that correlates with exacerbation of lupus-like autoimmune responses in SNF1 mice.


We would like to thank Ms. Melissa R. Makris, Flow Cytometry Lab Supervisor, for her assistance with the flow cytometry data analysis and Flowjo software. The authors wish to express their gratitude to Dr. Christopher Reilly for his guidance on staining and evaluating the kidneys and Dr. S. Ansar Ahmed for his critical review of this manuscript.

Funding: This work was supported by NIHR21-PAR-03-121.

Supported by NIH R21-PAR-03-121


  • Adams S, Zordan T, Sainis K, Datta S. T cell receptor V beta genes expressed by IgG anti-DNA autoantibody-inducing T cells in lupus nephritis: forbidden receptors and double-negative T cells. Eur J Immunol. 1990;20(7):1435–1443. [PubMed]
  • Bagavant H, Thompson C, Ohno K, Setiady Y, Tung KS. Differential effect of neonatal thymectomy on systemic and organ-specific autoimmune disease. International immunology. 2002;14(12):1397–1406. [PubMed]
  • Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006;25(3):383–392. [PubMed]
  • Billiau A. Interferon-gamma in autoimmunity. Cytokine & growth factor reviews. 1996;7(1):25–34. [PubMed]
  • Blaylock BL, Holladay SD, Comment CE, Heindel JJ, Luster MI. Exposure to tetrachlorodibenzo-p-dioxin (TCDD) alters fetal thymocyte maturation. Toxicology and applied pharmacology. 1992;112(2):207–213. [PubMed]
  • Campbell IL, Kay TW, Oxbrow L, Harrison LC. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. The Journal of clinical investigation. 1991;87(2):739–742. [PMC free article] [PubMed]
  • De Waal EJ, Schuurman HJ, Loeber JG, Van Loveren H, Vos JG. Alterations in the cortical thymic epithelium of rats after in vivo exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): an (immuno)histological study. Toxicology and applied pharmacology. 1992;115(1):80–88. [PubMed]
  • Dietert RR, Piepenbrink MS. Perinatal immunotoxicity: why adult exposure assessment fails to predict risk. Environmental health perspectives. 2006;114(4):477–483. [PMC free article] [PubMed]
  • Dong L, Ma Q, Whitlock JP., Jr. Down-regulation of major histocompatibility complex Q1b gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. The Journal of biological chemistry. 1997;272(47):29614–29619. [PubMed]
  • Eastcott JW, Schwartz RS, Datta SK. Genetic analysis of the inheritance of B cell hyperactivity in relation to the development of autoantibodies and glomerulonephritis in NZB x SWR crosses. J Immunol. 1983;131(5):2232–2239. [PubMed]
  • Fine JS, Gasiewicz TA, Silverstone AE. Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Molecular pharmacology. 1989;35(1):18–25. [PubMed]
  • Fournel S, Neichel S, Dali H, Farci S, Maillere B, Briand JP, Muller S. CD4+ T cells from (New Zealand Black × New Zealand White)F1 lupus mice and normal mice immunized against apoptotic nucleosomes recognize similar Th cell epitopes in the C terminus of histone H3. J Immunol. 2003;171(2):636–644. [PubMed]
  • Gehrs BC, Smialowicz RJ. Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology. 1999;134(1):79–88. [PubMed]
  • Haas C, Ryffel B, Le Hir M. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J Immunol. 1997;158(11):5484–5491. [PubMed]
  • Hanawa H, Tsuchida M, Matsumoto Y, Watanabe H, Abo T, Sekikawa H, Kodama M, Zhang S, Izumi T, Shibata A. Characterization of T cells infiltrating the heart in rats with experimental autoimmune myocarditis. Their similarity to extrathymic T cells in mice and the site of proliferation. J Immunol. 1993;150(12):5682–5695. [PubMed]
  • Hayashi Y, Haneji N, Hamano H. Cytokine gene expression and autoantibody production in Sjogren's syndrome of MRL/lpr mice. Autoimmunity. 1996;23(4):269–277. [PubMed]
  • Hogaboam JP, Moore AJ, Lawrence BP. The aryl hydrocarbon receptor affects distinct tissue compartments during ontogeny of the immune system. Toxicol Sci. 2008;102(1):160–170. [PMC free article] [PubMed]
  • Holladay SD. Prenatal immunotoxicant exposure and postnatal autoimmune disease. Environmental health perspectives. 1999;107(Suppl 5):687–691. [PMC free article] [PubMed]
  • Holladay SD, Lindstrom P, Blaylock BL, Comment CE, Germolec DR, Heindell JJ, Luster MI. Perinatal thymocyte antigen expression and postnatal immune development altered by gestational exposure to tetrachlorodibenzo-p-dioxin (TCDD) Teratology. 1991;44(4):385–393. [PubMed]
  • Holladay SD, Smialowicz RJ. Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure. Environmental health perspectives. 2000;108(Suppl 3):463–473. [PMC free article] [PubMed]
  • Hundeiker C, Pineau T, Cassar G, Betensky RA, Gleichmann E, Esser C. Thymocyte development in Ah-receptor-deficient mice is refractory to TCDD-inducible changes. International journal of immunopharmacology. 1999;21(12):841–859. [PubMed]
  • Kakkanaiah VN, Pyle RH, Nagarkatti M, Nagarkatti PS. Evidence for major alterations in the thymocyte subpopulations in murine models of autoimmune diseases. Journal of autoimmunity. 1990;3(3):271–288. [PubMed]
  • Kang HK, Liu M, Datta SK. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol. 2007;178(12):7849–7858. [PubMed]
  • Karpuzoglu-Sahin E, Hissong BD, Ansar Ahmed S. Interferon-gamma levels are upregulated by 17-beta-estradiol and diethylstilbestrol. J Reprod Immunol. 2001a;52(1–2):113–127. [PubMed]
  • Karpuzoglu-Sahin E, Zhi-Jun Y, Lengi A, Sriranganathan N, Ansar Ahmed S. Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice. Cytokine. 2001b;14(4):208–217. [PubMed]
  • Kruisbeek AM, Titus JA, Stephany DA, Gause BL, Longo DL. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens. J Immunol. 1985;134(6):3605–3614. [PubMed]
  • Marshall NB, Vorachek WR, Steppan LB, Mourich DV, Kerkvliet NI. Functional characterization and gene expression analysis of CD4+ CD25+ regulatory T cells generated in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Immunol. 2008;181(4):2382–2391. [PubMed]
  • McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol. 2007;8(12):1390–1397. [PubMed]
  • Michaels MA, Kang HK, Kaliyaperumal A, Satyaraj E, Shi Y, Datta SK. A defect in deletion of nucleosome-specific autoimmune T cells in lupus-prone thymus: role of thymic dendritic cells. J Immunol. 2005;175(9):5857–5865. [PubMed]
  • Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993;177(5):1367–1381. [PMC free article] [PubMed]
  • Mustafa A, Holladay SD, Goff M, Witonsky SG, Kerr R, Reilly CM, Sponenberg DP, Gogal RM., Jr. An enhanced postnatal autoimmune profile in 24 week-old C57BL/6 mice developmentally exposed to TCDD. Toxicology and applied pharmacology. 2008;232(1):51–59. [PMC free article] [PubMed]
  • Nicoletti F, Meroni P, Di Marco R, Barcellini W, Borghi MO, Gariglio M, Mattina A, Grasso S, Landolfo S. In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse. Immunopharmacology. 1992;24(1):11–16. [PubMed]
  • O'Garra A, Chang R, Go N, Hastings R, Haughton G, Howard M. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. European journal of immunology. 1992;22(3):711–717. [PubMed]
  • Okuyama R, Abo T, Seki S, Ohteki T, Sugiura K, Kusumi A, Kumagai K. Estrogen administration activates extrathymic T cell differentiation in the liver. The Journal of experimental medicine. 1992;175(3):661–669. [PMC free article] [PubMed]
  • Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, Caccamo M, Oukka M, Weiner HL. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008;453(7191):65–71. [PubMed]
  • Rajagopalan S, Zordan T, Tsokos GC, Datta SK. Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8- T helper cell lines that express the gamma delta T-cell antigen receptor. Proceedings of the National Academy of Sciences of the United States of America. 1990;87(18):7020–7024. [PubMed]
  • Rocha B, Vassalli P, Guy-Grand D. The extrathymic T-cell development pathway. Immunology today. 1992;13(11):449–454. [PubMed]
  • Shivakumar S, Tsokos GC, Datta SK. T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol. 1989;143(1):103–112. [PubMed]
  • Silverstone A, Gavalchin J, Silvin C, Staples J, Ames I, Shanley P. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on a murine model of a lupus-like nephritis. Chemosphere. 1998;18(11–23)
  • Silverstone AE, Frazier DE, Jr., Gasiewicz TA. Alternate immune system targets for TCDD: lymphocyte stem cells and extrathymic T-cell development. Experimental and clinical immunogenetics. 1994;11(2–3):94–101. [PubMed]
  • Vorderstrasse BA, Dearstyne EA, Kerkvliet NI. Influence of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antigen-presenting activity of dendritic cells. Toxicol Sci. 2003;72(1):103–112. [PubMed]
  • Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J. IL-10 regulates murine lupus. J Immunol. 2002;169(4):2148–2155. [PubMed]